Health

President Donald Trump gives a thumbs up as he walks with Vice President Mike Pence as he departs Capitol Hill in Washington, Thursday, Nov. 16, 2017. Trump urged House Republicans Thursday to approve a near $1.5 trillion tax overhaul as the party prepared to drive the measure through the House. Across the Capitol, Democrats pointed to new numbers showing the Senate version of the plan would boost taxes on lower and middle-income Americans. (AP Photo/Susan Walsh)
November 16, 2017 - 8:28 pm
WASHINGTON (AP) — The Latest on House consideration of the tax overhaul (all times local): 8:20 p.m. Vice President Mike Pence says "now the ball is in the Senate's court," after the House voted Thursday to approve a $1.5 trillion overhaul of the nation's tax code. At the Tax Foundation's 80th...
Read More
This photo provided by Genentech, Inc. shows a package of the drug Hemlibra. On Thursday, Nov. 16, 2017, the Food and Drug Administration approved Hemlibra, the first new treatment in nearly two decades to prevent internal bleeding in certain patients with hemophilia, an inherited blood-clotting disorder. (Genentech, Inc. via AP)
November 16, 2017 - 6:07 pm
TRENTON, N.J. (AP) — U.S. regulators have approved the first new treatment in nearly two decades to prevent internal bleeding in certain patients with hemophilia. The Food and Drug Administration on Thursday approved Hemlibra, a weekly self-injection for hemophilia A patients who have developed...
Read More
FILE - In this Oct. 26, 2017 file photo, Insys Therapeutics founder John Kapoor leaves U.S. District Court in Phoenix. He had been charged with leading a conspiracy to bribe doctors to prescribe an opioid pain medication for people who didn't need it. Kapoor is scheduled for arraignment Thursday, Nov. 16, in federal court Boston. (AP Photo/Ross D. Franklin, File)
November 16, 2017 - 4:16 pm
BOSTON (AP) — A pharmaceutical company founder accused of leading a conspiracy to bribe doctors to prescribe a powerful opioid pain medication will fight the charges against him and believes he will be vindicated, his attorney said Thursday. John Kapoor, of Insys Therapeutics Inc., pleaded not...
Read More
President Donald Trump gives a thumbs up as he walks with Vice President Mike Pence as he departs Capitol Hill in Washington, Thursday, Nov. 16, 2017. Trump urged House Republicans Thursday to approve a near $1.5 trillion tax overhaul as the party prepared to drive the measure through the House. Across the Capitol, Democrats pointed to new numbers showing the Senate version of the plan would boost taxes on lower and middle-income Americans. (AP Photo/Susan Walsh)
November 16, 2017 - 3:29 pm
WASHINGTON (AP) — The Latest on House consideration of the tax overhaul (all times local): 3:28 p.m. President Donald Trump talked about his efforts to release three American basketball players from detention in China as he rallied House Republicans before a crucial vote on tax reform. Trump also...
Read More
November 16, 2017 - 3:21 pm
WASHINGTON (AP) — U.S. health authorities announced plans Thursday to crack down on doctors pushing stem cell procedures that pose the gravest risks to patients amid an effort to police a burgeoning medical field that previously has received little oversight. The Food and Drug Administration laid...
Read More
House Ways and Means Chair Rep. Kevin Brady, R-Texas, center, is welcomed by House Republicans including from left, House Majority Leader Kevin McCarthy of Calif., House Speaker Paul Ryan of Wis., Rep. Carlos Curbelo, R-Fla., and Rep. Cathy McMorris Rodgers, R-Wash., as they arrive to speak to the media following a vote on the GOP tax bill, Thursday, Nov. 16, 2017, on Capitol Hill in Washington. (AP Photo/Jacquelyn Martin)
November 16, 2017 - 2:36 pm
WASHINGTON (AP) — Republicans rammed a near $1.5 trillion package overhauling corporate and personal taxes through the House on Thursday, edging President Donald Trump and the GOP toward their first big legislative triumph in a year in which they and their voters expected much more. The near party-...
Read More
FILE - In this Oct. 26, 2017 file photo, Insys Therapeutics founder John Kapoor leaves U.S. District Court in Phoenix. He had been charged with leading a conspiracy to bribe doctors to prescribe an opioid pain medication for people who didn't need it. Kapoor is scheduled for arraignment Thursday, Nov. 16, in federal court Boston. (AP Photo/Ross D. Franklin, File)
November 16, 2017 - 2:13 pm
BOSTON (AP) — A pharmaceutical company founder accused of leading a nationwide conspiracy to bribe doctors to prescribe a powerful opioid pain medication will fight the charges against him and believes he will be vindicated, his attorney said Thursday. John Kapoor, of Insys Therapeutics Inc.,...
Read More
President Donald Trump leaves Capitol Hill after meeting with lawmakers on tax policy, Thursday, Nov. 16, 2017, in Washington. Trump urged House Republicans Thursday to approve a near $1.5 trillion tax overhaul as the party prepared to drive the measure through the House. Across the Capitol, Democrats pointed to new numbers showing the Senate version of the plan would boost taxes on lower and middle-income Americans. (AP Photo/Evan Vucci)
November 16, 2017 - 1:52 pm
WASHINGTON (AP) — The Latest on House consideration of the tax overhaul (all times local): 1:50 p.m. The House has passed a sweeping Republican tax bill cutting taxes for corporations and many people. It puts GOP leaders closer to delivering to President Donald Trump a crucial legislative...
Read More
November 16, 2017 - 1:30 pm
DENVER (AP) — A watchdog arm of the U.S. Department of Veterans Affairs said Thursday that the agency's Denver-area hospital violated policy by keeping improper wait lists to track veterans' mental health care. Investigators with the VA Office of Inspector General confirmed a whistleblower's claim...
Read More
This photo provided by Genentech, Inc. shows a package of the drug Hemlibra. On Thursday, Nov. 16, 2017, the Food and Drug Administration approved Hemlibra, the first new treatment in nearly two decades to prevent internal bleeding in certain patients with hemophilia, an inherited blood-clotting disorder. (Genentech, Inc. via AP)
November 16, 2017 - 1:29 pm
TRENTON, N.J. (AP) — U.S. regulators have approved the first new treatment in nearly two decades to prevent internal bleeding in certain patients with hemophilia, an inherited blood-clotting disorder. The Food and Drug Administration on Thursday approved Hemlibra (hem-LEE'-bruh), a weekly injection...
Read More

Pages